Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Submitted by
admin
on August 21, 2015 - 5:24pm
Source:
Bloomberg
News Tags:
Merck
Januvia
Janumet
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Headline:
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Do Not Allow Advertisers to Use My Personal information